Macko Todd D
Chief Financial Officer
Macko Todd D has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Mar 30, 2026.
On the most recent filing, Macko Todd D is listed as Chief Financial Officer at IMPACT BIOMEDICAL INC. Inside the rolling window, Macko Todd D reported no open-market purchases and 2 open-market sales totaling $25K in IBO. The largest disclosed transaction in the window is a sale of 43,400 IBO shares on Mar 27, 2026, worth $24K.
Companies traded
Other insiders at IBO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$25K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Macko Todd D made?
Macko Todd D has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Macko Todd D trade?
Macko Todd D has filed SEC Form 4 disclosures for 1 company, including IBO.
When was Macko Todd D's most recent SEC Form 4 filing?
Macko Todd D's most recent SEC Form 4 filing on Tracefour is dated Mar 30, 2026.
What is Macko Todd D's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Macko Todd D is listed as Chief Financial Officer.
What is Macko Todd D's total buy and sell value in the current window?
Inside the rolling retention window, Macko Todd D bought $0 and sold $25K based on SEC Form 4 filings.
What was Macko Todd D's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 43,400 IBO shares on 2026-03-27, worth $24K, per SEC Form 4 filings.